Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019) 2687-2693].
Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019) 2687-2693].
Vaccine. 2020 Mar 19;:
Authors: Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K
PMID: 32201139 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Japan Health | Meningitis Vaccine | Pediatrics | Pneomococcal Vaccine | Pneumonia | Science | Study | Vaccines